<!DOCTYPE us-patent-grant SYSTEM "us-patent-grant-v44-2013-05-16.dtd" [ ]>
<us-patent-grant lang="EN" dtd-version="v4.4 2013-05-16" file="US08626525-20140107.XML" status="PRODUCTION" id="us-patent-grant" country="US" date-produced="20131224" date-publ="20140107">
<us-bibliographic-data-grant>
<publication-reference>
<document-id>
<country>US</country>
<doc-number>08626525</doc-number>
<kind>B2</kind>
<date>20140107</date>
</document-id>
</publication-reference>
<application-reference appl-type="utility">
<document-id>
<country>US</country>
<doc-number>12144293</doc-number>
<date>20080623</date>
</document-id>
</application-reference>
<us-application-series-code>12</us-application-series-code>
<us-term-of-grant>
<us-term-extension>511</us-term-extension>
</us-term-of-grant>
<classifications-ipcr>
<classification-ipcr>
<ipc-version-indicator><date>20120101</date></ipc-version-indicator>
<classification-level>A</classification-level>
<section>G</section>
<class>06</class>
<subclass>Q</subclass>
<main-group>10</main-group>
<subgroup>00</subgroup>
<symbol-position>F</symbol-position>
<classification-value>I</classification-value>
<action-date><date>20140107</date></action-date>
<generating-office><country>US</country></generating-office>
<classification-status>B</classification-status>
<classification-data-source>H</classification-data-source>
</classification-ipcr>
</classifications-ipcr>
<classification-national>
<country>US</country>
<main-classification>705  2</main-classification>
<further-classification>705  3</further-classification>
</classification-national>
<invention-title id="d2e53">Systems and methods for real-time monitoring and analysis of prescription claim rejections</invention-title>
<us-references-cited>
<us-citation>
<patcit num="00001">
<document-id>
<country>US</country>
<doc-number>4674041</doc-number>
<kind>A</kind>
<name>Lemon et al.</name>
<date>19870600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00002">
<document-id>
<country>US</country>
<doc-number>4723212</doc-number>
<kind>A</kind>
<name>Mindrum et al.</name>
<date>19880200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00003">
<document-id>
<country>US</country>
<doc-number>4910672</doc-number>
<kind>A</kind>
<name>Off et al.</name>
<date>19900300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00004">
<document-id>
<country>US</country>
<doc-number>5007641</doc-number>
<kind>A</kind>
<name>Seidman</name>
<date>19910400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00005">
<document-id>
<country>US</country>
<doc-number>5080364</doc-number>
<kind>A</kind>
<name>Seidman</name>
<date>19920100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00006">
<document-id>
<country>US</country>
<doc-number>5173851</doc-number>
<kind>A</kind>
<name>Off et al.</name>
<date>19921200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00007">
<document-id>
<country>US</country>
<doc-number>5201010</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19930400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00008">
<document-id>
<country>US</country>
<doc-number>5235702</doc-number>
<kind>A</kind>
<name>Miller</name>
<date>19930800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00009">
<document-id>
<country>US</country>
<doc-number>5237620</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19930800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00010">
<document-id>
<country>US</country>
<doc-number>5301105</doc-number>
<kind>A</kind>
<name>Cummings</name>
<date>19940400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00011">
<document-id>
<country>US</country>
<doc-number>5305196</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19940400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00012">
<document-id>
<country>US</country>
<doc-number>5327508</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19940700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00013">
<document-id>
<country>US</country>
<doc-number>5359509</doc-number>
<kind>A</kind>
<name>Little et al.</name>
<date>19941000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00014">
<document-id>
<country>US</country>
<doc-number>5388165</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19950200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00015">
<document-id>
<country>US</country>
<doc-number>5430644</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19950700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00016">
<document-id>
<country>US</country>
<doc-number>5448471</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19950900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00017">
<document-id>
<country>US</country>
<doc-number>5544044</doc-number>
<kind>A</kind>
<name>Leatherman</name>
<date>19960800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00018">
<document-id>
<country>US</country>
<doc-number>5550734</doc-number>
<kind>A</kind>
<name>Tarter et al.</name>
<date>19960800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00019">
<document-id>
<country>US</country>
<doc-number>5588649</doc-number>
<kind>A</kind>
<name>Blumberg et al.</name>
<date>19961200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00020">
<document-id>
<country>US</country>
<doc-number>5592560</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19970100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00021">
<document-id>
<country>US</country>
<doc-number>5612868</doc-number>
<kind>A</kind>
<name>Off et al.</name>
<date>19970300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00022">
<document-id>
<country>US</country>
<doc-number>5621812</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19970400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00023">
<document-id>
<country>US</country>
<doc-number>5628530</doc-number>
<kind>A</kind>
<name>Thornton</name>
<date>19970500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00024">
<document-id>
<country>US</country>
<doc-number>5638457</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19970600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00025">
<document-id>
<country>US</country>
<doc-number>5642485</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19970600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00026">
<document-id>
<country>US</country>
<doc-number>5644723</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19970700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00027">
<document-id>
<country>US</country>
<doc-number>5644778</doc-number>
<kind>A</kind>
<name>Burks et al.</name>
<date>19970700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00028">
<document-id>
<country>US</country>
<doc-number>5649114</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19970700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00029">
<document-id>
<country>US</country>
<doc-number>5659469</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19970800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00030">
<document-id>
<country>US</country>
<doc-number>5675662</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19971000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00031">
<document-id>
<country>US</country>
<doc-number>5687322</doc-number>
<kind>A</kind>
<name>Deaton et al.</name>
<date>19971100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00032">
<document-id>
<country>US</country>
<doc-number>5704044</doc-number>
<kind>A</kind>
<name>Tarter et al.</name>
<date>19971200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00033">
<document-id>
<country>US</country>
<doc-number>5748907</doc-number>
<kind>A</kind>
<name>Crane</name>
<date>19980500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00034">
<document-id>
<country>US</country>
<doc-number>5749907</doc-number>
<kind>A</kind>
<name>Mann</name>
<date>19980500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00035">
<document-id>
<country>US</country>
<doc-number>5832447</doc-number>
<kind>A</kind>
<name>Rieker et al.</name>
<date>19981100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00036">
<document-id>
<country>US</country>
<doc-number>5832457</doc-number>
<kind>A</kind>
<name>O'Brien</name>
<date>19981100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00037">
<document-id>
<country>US</country>
<doc-number>5845255</doc-number>
<kind>A</kind>
<name>Mayaud</name>
<date>19981200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00038">
<document-id>
<country>US</country>
<doc-number>5857175</doc-number>
<kind>A</kind>
<name>Day et al.</name>
<date>19990100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00039">
<document-id>
<country>US</country>
<doc-number>5892827</doc-number>
<kind>A</kind>
<name>Beach et al.</name>
<date>19990400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00040">
<document-id>
<country>US</country>
<doc-number>5892900</doc-number>
<kind>A</kind>
<name>Ginter et al.</name>
<date>19990400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00041">
<document-id>
<country>US</country>
<doc-number>5915007</doc-number>
<kind>A</kind>
<name>Klapka</name>
<date>19990600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00042">
<document-id>
<country>US</country>
<doc-number>5926795</doc-number>
<kind>A</kind>
<name>Williams</name>
<date>19990700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00043">
<document-id>
<country>US</country>
<doc-number>5950169</doc-number>
<kind>A</kind>
<name>Borghesi et al.</name>
<date>19990900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00044">
<document-id>
<country>US</country>
<doc-number>5956736</doc-number>
<kind>A</kind>
<name>Hanson et al.</name>
<date>19990900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00045">
<document-id>
<country>US</country>
<doc-number>5963915</doc-number>
<kind>A</kind>
<name>Kirsch</name>
<date>19991000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00046">
<document-id>
<country>US</country>
<doc-number>5970469</doc-number>
<kind>A</kind>
<name>Scroggie et al.</name>
<date>19991000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00047">
<document-id>
<country>US</country>
<doc-number>5974399</doc-number>
<kind>A</kind>
<name>Giuliani et al.</name>
<date>19991000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00048">
<document-id>
<country>US</country>
<doc-number>5991750</doc-number>
<kind>A</kind>
<name>Watson</name>
<date>19991100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00049">
<document-id>
<country>US</country>
<doc-number>6006242</doc-number>
<kind>A</kind>
<name>Poole et al.</name>
<date>19991200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00050">
<document-id>
<country>US</country>
<doc-number>6012035</doc-number>
<kind>A</kind>
<name>Freeman, Jr. et al.</name>
<date>20000100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00051">
<document-id>
<country>US</country>
<doc-number>6014634</doc-number>
<kind>A</kind>
<name>Scroggie et al.</name>
<date>20000100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00052">
<document-id>
<country>US</country>
<doc-number>6021392</doc-number>
<kind>A</kind>
<name>Lester et al.</name>
<date>20000200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00053">
<document-id>
<country>US</country>
<doc-number>6026370</doc-number>
<kind>A</kind>
<name>Jermyn</name>
<date>20000200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00054">
<document-id>
<country>US</country>
<doc-number>6041309</doc-number>
<kind>A</kind>
<name>Laor</name>
<date>20000300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00055">
<document-id>
<country>US</country>
<doc-number>6055573</doc-number>
<kind>A</kind>
<name>Gardenswartz et al.</name>
<date>20000400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00056">
<document-id>
<country>US</country>
<doc-number>6067069</doc-number>
<kind>A</kind>
<name>Krause</name>
<date>20000500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00057">
<document-id>
<country>US</country>
<doc-number>6067524</doc-number>
<kind>A</kind>
<name>Byerly et al.</name>
<date>20000500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00058">
<document-id>
<country>US</country>
<doc-number>6073104</doc-number>
<kind>A</kind>
<name>Field</name>
<date>20000600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00059">
<document-id>
<country>US</country>
<doc-number>6185541</doc-number>
<kind>B1</kind>
<name>Scroggie et al.</name>
<date>20010200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00060">
<document-id>
<country>US</country>
<doc-number>6195612</doc-number>
<kind>B1</kind>
<name>Pack-Harris</name>
<date>20010200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00061">
<document-id>
<country>US</country>
<doc-number>6202923</doc-number>
<kind>B1</kind>
<name>Boyer et al.</name>
<date>20010300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00062">
<document-id>
<country>US</country>
<doc-number>6205455</doc-number>
<kind>B1</kind>
<name>Umen</name>
<date>20010300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00063">
<document-id>
<country>US</country>
<doc-number>6208973</doc-number>
<kind>B1</kind>
<name>Boyer et al.</name>
<date>20010300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00064">
<document-id>
<country>US</country>
<doc-number>6224387</doc-number>
<kind>B1</kind>
<name>Jones</name>
<date>20010500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00065">
<document-id>
<country>US</country>
<doc-number>6240394</doc-number>
<kind>B1</kind>
<name>Uecker</name>
<date>20010500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00066">
<document-id>
<country>US</country>
<doc-number>6260758</doc-number>
<kind>B1</kind>
<name>Blumberg</name>
<date>20010700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00067">
<document-id>
<country>US</country>
<doc-number>6278979</doc-number>
<kind>B1</kind>
<name>Williams</name>
<date>20010800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00068">
<document-id>
<country>US</country>
<doc-number>6282516</doc-number>
<kind>B1</kind>
<name>Giuliani</name>
<date>20010800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00069">
<document-id>
<country>US</country>
<doc-number>6298330</doc-number>
<kind>B1</kind>
<name>Gardenswartz et al.</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00070">
<document-id>
<country>US</country>
<doc-number>6304849</doc-number>
<kind>B1</kind>
<name>Uecker et al.</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00071">
<document-id>
<country>US</country>
<doc-number>6307940</doc-number>
<kind>B1</kind>
<name>Yamamoto et al.</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00072">
<document-id>
<country>US</country>
<doc-number>6307958</doc-number>
<kind>B1</kind>
<name>Deaton et al.</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00073">
<document-id>
<country>US</country>
<doc-number>6321210</doc-number>
<kind>B1</kind>
<name>O'Brien et al.</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00074">
<document-id>
<country>US</country>
<doc-number>6324516</doc-number>
<kind>B1</kind>
<name>Shults et al.</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00075">
<document-id>
<country>US</country>
<doc-number>6330546</doc-number>
<kind>B1</kind>
<name>Gopinathan et al.</name>
<date>20011200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00076">
<document-id>
<country>US</country>
<doc-number>6334108</doc-number>
<kind>B1</kind>
<name>Deaton et al.</name>
<date>20011200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00077">
<document-id>
<country>US</country>
<doc-number>6341265</doc-number>
<kind>B1</kind>
<name>Provost et al.</name>
<date>20020100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00078">
<document-id>
<country>US</country>
<doc-number>6343271</doc-number>
<kind>B1</kind>
<name>Peterson et al.</name>
<date>20020100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00079">
<document-id>
<country>US</country>
<doc-number>6351735</doc-number>
<kind>B1</kind>
<name>Deaton et al.</name>
<date>20020200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00080">
<document-id>
<country>US</country>
<doc-number>6377935</doc-number>
<kind>B1</kind>
<name>Deaton et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00081">
<document-id>
<country>US</country>
<doc-number>6424949</doc-number>
<kind>B1</kind>
<name>Deaton et al.</name>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00082">
<document-id>
<country>US</country>
<doc-number>6427020</doc-number>
<kind>B1</kind>
<name>Rhoads</name>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00083">
<document-id>
<country>US</country>
<doc-number>6484146</doc-number>
<kind>B2</kind>
<name>Day et al.</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00084">
<document-id>
<country>US</country>
<doc-number>6584448</doc-number>
<kind>B1</kind>
<name>Laor</name>
<date>20030600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00085">
<document-id>
<country>US</country>
<doc-number>6632251</doc-number>
<kind>B1</kind>
<name>Rutten et al.</name>
<date>20031000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00086">
<document-id>
<country>US</country>
<doc-number>6671692</doc-number>
<kind>B1</kind>
<name>Marpe et al.</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00087">
<document-id>
<country>US</country>
<doc-number>6671693</doc-number>
<kind>B1</kind>
<name>Marpe et al.</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00088">
<document-id>
<country>US</country>
<doc-number>6684195</doc-number>
<kind>B1</kind>
<name>Deaton et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00089">
<document-id>
<country>US</country>
<doc-number>6698013</doc-number>
<kind>B1</kind>
<name>Bertero et al.</name>
<date>20040200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00090">
<document-id>
<country>US</country>
<doc-number>6714918</doc-number>
<kind>B2</kind>
<name>Hillmer et al.</name>
<date>20040300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00091">
<document-id>
<country>US</country>
<doc-number>6757898</doc-number>
<kind>B1</kind>
<name>Ilsen et al.</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00092">
<document-id>
<country>US</country>
<doc-number>6769228</doc-number>
<kind>B1</kind>
<name>Mahar</name>
<date>20040800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00093">
<document-id>
<country>US</country>
<doc-number>6795809</doc-number>
<kind>B2</kind>
<name>O'Brien et al.</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00094">
<document-id>
<country>US</country>
<doc-number>6879959</doc-number>
<kind>B1</kind>
<name>Chapman et al.</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00095">
<document-id>
<country>US</country>
<doc-number>6885994</doc-number>
<kind>B1</kind>
<name>Scroggie et al.</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00096">
<document-id>
<country>US</country>
<doc-number>7013284</doc-number>
<kind>B2</kind>
<name>Guyan et al.</name>
<date>20060300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00097">
<document-id>
<country>US</country>
<doc-number>7024374</doc-number>
<kind>B1</kind>
<name>Day et al.</name>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00098">
<document-id>
<country>US</country>
<doc-number>7058584</doc-number>
<kind>B2</kind>
<name>Kosinski et al.</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00099">
<document-id>
<country>US</country>
<doc-number>7058591</doc-number>
<kind>B2</kind>
<name>Giuliani et al.</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00100">
<document-id>
<country>US</country>
<doc-number>7111173</doc-number>
<kind>B1</kind>
<name>Scheidt</name>
<date>20060900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00101">
<document-id>
<country>US</country>
<doc-number>7155397</doc-number>
<kind>B2</kind>
<name>Alexander et al.</name>
<date>20061200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00102">
<document-id>
<country>US</country>
<doc-number>7225052</doc-number>
<kind>B2</kind>
<name>Foote et al.</name>
<date>20070500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00103">
<document-id>
<country>US</country>
<doc-number>7228285</doc-number>
<kind>B2</kind>
<name>Hull et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00104">
<document-id>
<country>US</country>
<doc-number>7233913</doc-number>
<kind>B2</kind>
<name>Scroggie et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00105">
<document-id>
<country>US</country>
<doc-number>7309001</doc-number>
<kind>B2</kind>
<name>Banfield et al.</name>
<date>20071200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00106">
<document-id>
<country>US</country>
<doc-number>7356460</doc-number>
<kind>B1</kind>
<name>Kennedy et al.</name>
<date>20080400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00107">
<document-id>
<country>US</country>
<doc-number>7380707</doc-number>
<kind>B1</kind>
<name>Fredman</name>
<date>20080600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00108">
<document-id>
<country>US</country>
<doc-number>7401027</doc-number>
<kind>B2</kind>
<name>Moore et al.</name>
<date>20080700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00109">
<document-id>
<country>US</country>
<doc-number>7415426</doc-number>
<kind>B2</kind>
<name>Williams et al.</name>
<date>20080800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00110">
<document-id>
<country>US</country>
<doc-number>7418400</doc-number>
<kind>B1</kind>
<name>Lorenz</name>
<date>20080800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00111">
<document-id>
<country>US</country>
<doc-number>7426480</doc-number>
<kind>B2</kind>
<name>Granger et al.</name>
<date>20080900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00112">
<document-id>
<country>US</country>
<doc-number>2001/0001014</doc-number>
<kind>A1</kind>
<name>Akins, III et al.</name>
<date>20010500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00113">
<document-id>
<country>US</country>
<doc-number>2001/0032099</doc-number>
<kind>A1</kind>
<name>Joao</name>
<date>20011000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00114">
<document-id>
<country>US</country>
<doc-number>2001/0037216</doc-number>
<kind>A1</kind>
<name>Oscar et al.</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00115">
<document-id>
<country>US</country>
<doc-number>2001/0037224</doc-number>
<kind>A1</kind>
<name>Eldridge et al.</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00116">
<document-id>
<country>US</country>
<doc-number>2001/0041993</doc-number>
<kind>A1</kind>
<name>Campbell</name>
<date>20011100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00117">
<document-id>
<country>US</country>
<doc-number>2002/0002495</doc-number>
<kind>A1</kind>
<name>Ullman</name>
<date>20020100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00118">
<document-id>
<country>US</country>
<doc-number>2002/0035488</doc-number>
<kind>A1</kind>
<name>Aquila et al.</name>
<date>20020300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00119">
<document-id>
<country>US</country>
<doc-number>2002/0044043</doc-number>
<kind>A1</kind>
<name>Chaco et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00120">
<document-id>
<country>US</country>
<doc-number>2002/0049617</doc-number>
<kind>A1</kind>
<name>Lencki et al.</name>
<date>20020400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00121">
<document-id>
<country>US</country>
<doc-number>2002/0055856</doc-number>
<kind>A1</kind>
<name>Adams</name>
<date>20020500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00122">
<document-id>
<country>US</country>
<doc-number>2002/0065687</doc-number>
<kind>A1</kind>
<name>Onoue</name>
<date>20020500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00123">
<document-id>
<country>US</country>
<doc-number>2002/0087554</doc-number>
<kind>A1</kind>
<name>Seelinger</name>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00124">
<document-id>
<country>US</country>
<doc-number>2002/0087583</doc-number>
<kind>A1</kind>
<name>Morgan et al.</name>
<date>20020700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00125">
<document-id>
<country>US</country>
<doc-number>2002/0111832</doc-number>
<kind>A1</kind>
<name>Judge</name>
<date>20020800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00126">
<document-id>
<country>US</country>
<doc-number>2002/0120473</doc-number>
<kind>A1</kind>
<name>Wiggins</name>
<date>20020800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00127">
<document-id>
<country>US</country>
<doc-number>2002/0128883</doc-number>
<kind>A1</kind>
<name>Harris</name>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00128">
<document-id>
<country>US</country>
<doc-number>2002/0133503</doc-number>
<kind>A1</kind>
<name>Amar et al.</name>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00129">
<document-id>
<country>US</country>
<doc-number>2002/0138593</doc-number>
<kind>A1</kind>
<name>Novak et al.</name>
<date>20020900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00130">
<document-id>
<country>US</country>
<doc-number>2002/0175370</doc-number>
<kind>A1</kind>
<name>Bockelman</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00131">
<document-id>
<country>US</country>
<doc-number>2002/0183979</doc-number>
<kind>A1</kind>
<name>Wildman</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00132">
<document-id>
<country>US</country>
<doc-number>2002/0198831</doc-number>
<kind>A1</kind>
<name>Patricelli et al.</name>
<date>20021200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00133">
<document-id>
<country>US</country>
<doc-number>2003/0009357</doc-number>
<kind>A1</kind>
<name>Pish</name>
<date>20030100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00134">
<document-id>
<country>US</country>
<doc-number>2003/0009367</doc-number>
<kind>A1</kind>
<name>Morrison</name>
<date>20030100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00135">
<document-id>
<country>US</country>
<doc-number>2003/0028404</doc-number>
<kind>A1</kind>
<name>Herron et al.</name>
<date>20030200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00136">
<document-id>
<country>US</country>
<doc-number>2003/0050799</doc-number>
<kind>A1</kind>
<name>Jay et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00137">
<document-id>
<country>US</country>
<doc-number>2003/0069760</doc-number>
<kind>A1</kind>
<name>Gelber</name>
<date>20030400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00138">
<document-id>
<country>US</country>
<doc-number>2003/0074218</doc-number>
<kind>A1</kind>
<name>Liff et al.</name>
<date>20030400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00139">
<document-id>
<country>US</country>
<doc-number>2003/0074222</doc-number>
<kind>A1</kind>
<name>Rosow et al.</name>
<date>20030400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00140">
<document-id>
<country>US</country>
<doc-number>2003/0074345</doc-number>
<kind>A1</kind>
<name>Baldwin et al.</name>
<date>20030400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00141">
<document-id>
<country>US</country>
<doc-number>2003/0083903</doc-number>
<kind>A1</kind>
<name>Myers</name>
<date>20030500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00142">
<document-id>
<country>US</country>
<doc-number>2003/0120588</doc-number>
<kind>A1</kind>
<name>Dodd et al.</name>
<date>20030600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00143">
<document-id>
<country>US</country>
<doc-number>2003/0125986</doc-number>
<kind>A1</kind>
<name>Collosi</name>
<date>20030700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00144">
<document-id>
<country>US</country>
<doc-number>2003/0130875</doc-number>
<kind>A1</kind>
<name>Hawash et al.</name>
<date>20030700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00145">
<document-id>
<country>US</country>
<doc-number>2003/0149594</doc-number>
<kind>A1</kind>
<name>Beazley et al.</name>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00146">
<document-id>
<country>US</country>
<doc-number>2003/0149625</doc-number>
<kind>A1</kind>
<name>Leonardi et al.</name>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00147">
<document-id>
<country>US</country>
<doc-number>2003/0154163</doc-number>
<kind>A1</kind>
<name>Phillips et al.</name>
<date>20030800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00148">
<document-id>
<country>US</country>
<doc-number>2003/0229519</doc-number>
<kind>A1</kind>
<name>Eidex et al.</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>705  2</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00149">
<document-id>
<country>US</country>
<doc-number>2003/0229540</doc-number>
<kind>A1</kind>
<name>Algiene</name>
<date>20031200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00150">
<document-id>
<country>US</country>
<doc-number>2004/0006490</doc-number>
<kind>A1</kind>
<name>Gingrich et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00151">
<document-id>
<country>US</country>
<doc-number>2004/0019464</doc-number>
<kind>A1</kind>
<name>Martucci et al.</name>
<date>20040100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00152">
<document-id>
<country>US</country>
<doc-number>2004/0039599</doc-number>
<kind>A1</kind>
<name>Fralic</name>
<date>20040200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00153">
<document-id>
<country>US</country>
<doc-number>2004/0046020</doc-number>
<kind>A1</kind>
<name>Andreasson et al.</name>
<date>20040300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00154">
<document-id>
<country>US</country>
<doc-number>2004/0054657</doc-number>
<kind>A1</kind>
<name>Takeyama</name>
<date>20040300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00155">
<document-id>
<country>US</country>
<doc-number>2004/0073457</doc-number>
<kind>A1</kind>
<name>Kalies</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00156">
<document-id>
<country>US</country>
<doc-number>2004/0078234</doc-number>
<kind>A1</kind>
<name>Tallal</name>
<date>20040400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00157">
<document-id>
<country>US</country>
<doc-number>2004/0093242</doc-number>
<kind>A1</kind>
<name>Cadigan et al.</name>
<date>20040500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00158">
<document-id>
<country>US</country>
<doc-number>2004/0107117</doc-number>
<kind>A1</kind>
<name>Denny</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00159">
<document-id>
<country>US</country>
<doc-number>2004/0111277</doc-number>
<kind>A1</kind>
<name>Pearson et al.</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00160">
<document-id>
<country>US</country>
<doc-number>2004/0111291</doc-number>
<kind>A1</kind>
<name>Dust et al.</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00161">
<document-id>
<country>US</country>
<doc-number>2004/0117323</doc-number>
<kind>A1</kind>
<name>Mindala</name>
<date>20040600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00162">
<document-id>
<country>US</country>
<doc-number>2004/0133452</doc-number>
<kind>A1</kind>
<name>Denny et al.</name>
<date>20040700</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>705  2</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00163">
<document-id>
<country>US</country>
<doc-number>2004/0148198</doc-number>
<kind>A1</kind>
<name>Kalies</name>
<date>20040700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00164">
<document-id>
<country>US</country>
<doc-number>2004/0153336</doc-number>
<kind>A1</kind>
<name>Virdee et al.</name>
<date>20040800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00165">
<document-id>
<country>US</country>
<doc-number>2004/0172281</doc-number>
<kind>A1</kind>
<name>Stanners</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00166">
<document-id>
<country>US</country>
<doc-number>2004/0188998</doc-number>
<kind>A1</kind>
<name>Henthorn</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00167">
<document-id>
<country>US</country>
<doc-number>2004/0249745</doc-number>
<kind>A1</kind>
<name>Baaren</name>
<date>20041200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00168">
<document-id>
<country>US</country>
<doc-number>2005/0015280</doc-number>
<kind>A1</kind>
<name>Gabel et al.</name>
<date>20050100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00169">
<document-id>
<country>US</country>
<doc-number>2005/0033604</doc-number>
<kind>A1</kind>
<name>Hogan</name>
<date>20050200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00170">
<document-id>
<country>US</country>
<doc-number>2005/0033610</doc-number>
<kind>A1</kind>
<name>Cunningham</name>
<date>20050200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00171">
<document-id>
<country>US</country>
<doc-number>2005/0033736</doc-number>
<kind>A1</kind>
<name>Carlin et al.</name>
<date>20050200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00172">
<document-id>
<country>US</country>
<doc-number>2005/0060201</doc-number>
<kind>A1</kind>
<name>Connely, III et al.</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00173">
<document-id>
<country>US</country>
<doc-number>2005/0065821</doc-number>
<kind>A1</kind>
<name>Kalies</name>
<date>20050300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00174">
<document-id>
<country>US</country>
<doc-number>2005/0086081</doc-number>
<kind>A1</kind>
<name>Brock-Fisher</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00175">
<document-id>
<country>US</country>
<doc-number>2005/0090425</doc-number>
<kind>A1</kind>
<name>Reardan et al.</name>
<date>20050400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00176">
<document-id>
<country>US</country>
<doc-number>2005/0102169</doc-number>
<kind>A1</kind>
<name>Wilson</name>
<date>20050500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00177">
<document-id>
<country>US</country>
<doc-number>2005/0125292</doc-number>
<kind>A1</kind>
<name>Kassab et al.</name>
<date>20050600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00178">
<document-id>
<country>US</country>
<doc-number>2005/0154627</doc-number>
<kind>A1</kind>
<name>Zuzek et al.</name>
<date>20050700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00179">
<document-id>
<country>US</country>
<doc-number>2005/0171815</doc-number>
<kind>A1</kind>
<name>Vanderveen</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00180">
<document-id>
<country>US</country>
<doc-number>2005/0187793</doc-number>
<kind>A1</kind>
<name>Myles</name>
<date>20050800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00181">
<document-id>
<country>US</country>
<doc-number>2005/0197862</doc-number>
<kind>A1</kind>
<name>Paterson et al.</name>
<date>20050900</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00182">
<document-id>
<country>US</country>
<doc-number>2005/0240473</doc-number>
<kind>A1</kind>
<name>Ayers, Jr. et al.</name>
<date>20051000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00183">
<document-id>
<country>US</country>
<doc-number>2005/0261944</doc-number>
<kind>A1</kind>
<name>Rosenberger</name>
<date>20051100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00184">
<document-id>
<country>US</country>
<doc-number>2005/0288972</doc-number>
<kind>A1</kind>
<name>Marvin et al.</name>
<date>20051200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00185">
<document-id>
<country>US</country>
<doc-number>2006/0015518</doc-number>
<kind>A1</kind>
<name>Eletreby et al.</name>
<date>20060100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00186">
<document-id>
<country>US</country>
<doc-number>2006/0020514</doc-number>
<kind>A1</kind>
<name>Yered</name>
<date>20060100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00187">
<document-id>
<country>US</country>
<doc-number>2006/0026041</doc-number>
<kind>A1</kind>
<name>Ullman</name>
<date>20060200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00188">
<document-id>
<country>US</country>
<doc-number>2006/0085230</doc-number>
<kind>A1</kind>
<name>Brill et al.</name>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00189">
<document-id>
<country>US</country>
<doc-number>2006/0149587</doc-number>
<kind>A1</kind>
<name>Hill, Sr. et al.</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00190">
<document-id>
<country>US</country>
<doc-number>2006/0149784</doc-number>
<kind>A1</kind>
<name>Tholl et al.</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00191">
<document-id>
<country>US</country>
<doc-number>2006/0184391</doc-number>
<kind>A1</kind>
<name>Barre et al.</name>
<date>20060800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00192">
<document-id>
<country>US</country>
<doc-number>2006/0212318</doc-number>
<kind>A1</kind>
<name>Dooley et al.</name>
<date>20060900</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>705  4</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00193">
<document-id>
<country>US</country>
<doc-number>2006/0224415</doc-number>
<kind>A1</kind>
<name>Hudson et al.</name>
<date>20061000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00194">
<document-id>
<country>US</country>
<doc-number>2006/0229915</doc-number>
<kind>A1</kind>
<name>Kosinski et al.</name>
<date>20061000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00195">
<document-id>
<country>US</country>
<doc-number>2006/0247948</doc-number>
<kind>A1</kind>
<name>Ellis et al.</name>
<date>20061100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00196">
<document-id>
<country>US</country>
<doc-number>2006/0259363</doc-number>
<kind>A1</kind>
<name>Jhetam et al.</name>
<date>20061100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00197">
<document-id>
<country>US</country>
<doc-number>2006/0271398</doc-number>
<kind>A1</kind>
<name>Belcastro</name>
<date>20061100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00198">
<document-id>
<country>US</country>
<doc-number>2006/0271405</doc-number>
<kind>A1</kind>
<name>Cipolle et al.</name>
<date>20061100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00199">
<document-id>
<country>US</country>
<doc-number>2006/0287886</doc-number>
<kind>A1</kind>
<name>Kitazawa</name>
<date>20061200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00200">
<document-id>
<country>US</country>
<doc-number>2007/0005402</doc-number>
<kind>A1</kind>
<name>Kennedy et al.</name>
<date>20070100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00201">
<document-id>
<country>US</country>
<doc-number>2007/0050209</doc-number>
<kind>A1</kind>
<name>Yered</name>
<date>20070300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00202">
<document-id>
<country>US</country>
<doc-number>2007/0088576</doc-number>
<kind>A1</kind>
<name>de Beus et al.</name>
<date>20070400</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00203">
<document-id>
<country>US</country>
<doc-number>2007/0124177</doc-number>
<kind>A1</kind>
<name>Engleson et al.</name>
<date>20070500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00204">
<document-id>
<country>US</country>
<doc-number>2007/0136100</doc-number>
<kind>A1</kind>
<name>Daugherty et al.</name>
<date>20070600</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00205">
<document-id>
<country>US</country>
<doc-number>2007/0162433</doc-number>
<kind>A1</kind>
<name>Peters</name>
<date>20070700</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>707  3</main-classification></classification-national>
</us-citation>
<us-citation>
<patcit num="00206">
<document-id>
<country>US</country>
<doc-number>2007/0179957</doc-number>
<kind>A1</kind>
<name>Gibson et al.</name>
<date>20070800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00207">
<document-id>
<country>US</country>
<doc-number>2007/0233525</doc-number>
<kind>A1</kind>
<name>Boyle</name>
<date>20071000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00208">
<document-id>
<country>US</country>
<doc-number>2007/0233526</doc-number>
<kind>A1</kind>
<name>Hoffman et al.</name>
<date>20071000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00209">
<document-id>
<country>US</country>
<doc-number>2007/0239493</doc-number>
<kind>A1</kind>
<name>Sweetland et al.</name>
<date>20071000</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00210">
<document-id>
<country>US</country>
<doc-number>2008/0033750</doc-number>
<kind>A1</kind>
<name>Burriss et al.</name>
<date>20080200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00211">
<document-id>
<country>US</country>
<doc-number>2010/0211414</doc-number>
<kind>A1</kind>
<name>Tholl et al.</name>
<date>20100800</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00212">
<document-id>
<country>CA</country>
<doc-number>2482370</doc-number>
<kind>A1</kind>
<date>20060300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00213">
<document-id>
<country>EP</country>
<doc-number>1310895</doc-number>
<kind>A2</kind>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00214">
<document-id>
<country>WO</country>
<doc-number>9106917</doc-number>
<kind>A1</kind>
<date>19910500</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00215">
<document-id>
<country>WO</country>
<doc-number>9503569</doc-number>
<kind>A3</kind>
<date>19950200</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00216">
<document-id>
<country>WO</country>
<doc-number>9725682</doc-number>
<kind>A1</kind>
<date>19970700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00217">
<document-id>
<country>WO</country>
<doc-number>9850871</doc-number>
<kind>A1</kind>
<date>19981100</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00218">
<document-id>
<country>WO</country>
<doc-number>0039737</doc-number>
<kind>A1</kind>
<date>20000700</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<patcit num="00219">
<document-id>
<country>WO</country>
<doc-number>2007025295</doc-number>
<kind>A2</kind>
<date>20070300</date>
</document-id>
</patcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00220">
<othercit>Non-Final Office Action for U.S. Appl. No. 12/164,898 mailed Dec. 16, 2010.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00221">
<othercit>Non-final Office Action for U.S. Appl. No. 12/345,800 mailed Mar. 29, 2011.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00222">
<othercit>Final Office Action for U.S. Appl. No. 12/345,800 mailed Sep. 14, 2011.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00223">
<othercit>Final Office Action for U.S. Appl. No. 12/164,898 mailed May 26, 2011.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00224">
<othercit>Sampson, R.J., Taking Control of Health Care Costs, Best's Review&#x2014;Life Health Insurance Edition, Nov. 1983, pp. 64-66, vol. 84, Issue 7, USA.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00225">
<othercit>Anonymous, ACS to Demonstrate Electronic Health Record Solution Suite at MMIS 2007 Conference; EHR Tools Consolidate Data, Provide Useful Information at the Point of Care for Medicaid Providers, Payers, and Patients, PR Newswire, Aug. 13, 2007, New York, NY, USA.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00226">
<othercit>Lamb, J., New Era of Electronic Medicine Management: E-Prescriptions, Britain's Traditionally Cautious National Health Service is Starting Trials for Online Prescription, with the Aim of Cutting Costs. Financial Times, London, Feb. 21, 2001, p. 6, London, United Kingdom.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00227">
<othercit>Anonymous, Pharmacy Industry Leaders Launch Firm to Supply Real-Time Data. PR Newswire. Jul. 30, 2001, p. 1, New York, NY, USA.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00228">
<othercit>Anonymous, Medic: On-line Goes In-House, Chain Store Age Executive, Jan. 1987, pp. 128-32. vol. 63, Issue 1, USA.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00229">
<othercit>Anonymous, TechRx Announces Successful Beta Deployment of T-Rex. PR Newswire. May 13, 2002.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00230">
<othercit>&#x201c;Two automatic identification technology, neither new in the sense if being recent developments . . . &#x201d; Patient Safety &#x26; Quality Healthcare [Online] Aug. 2005. URL: http://www.awarix.com.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00231">
<othercit>&#x201c;Subnotebooks, Phones, and More. St. Vincent's Gets on Track.&#x201d; Mobile Health Data [Online], Nov. 19, 2004. URL: http://www.awarix.com.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00232">
<othercit>&#x201c;Coping with Information Overload.&#x201d; The News Source for Healthcare Information Technology [Online] Nov. 2004. URL: http://www.awarix.com.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00233">
<othercit>&#x201c;St. Vincent's first to use Birmingham startup's information system.&#x201d; The Birmingham News [Online] Apr. 11, 2005. URL: http://www.awarix.com.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00234">
<othercit>&#x201c;St. Vincent's is Digital Flagship&#x201d; D. Lockridge; Birmingham Medical News [Online] Sep. 2005. URL: http://www.awarix.com.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00235">
<othercit>Non-Final Office Action for U.S. Appl. No. 12/751,156 mailed Aug. 1, 2012.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00236">
<othercit>Final Office Action for U.S. Appl. No. 12/751,156 mailed Nov. 30, 2012.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
<us-citation>
<nplcit num="00237">
<othercit>Non-Final Office Action for U.S. Appl. No. 12/751,156 mailed Mar. 22, 2013.</othercit>
</nplcit>
<category>cited by applicant</category>
</us-citation>
</us-references-cited>
<number-of-claims>20</number-of-claims>
<us-exemplary-claim>1</us-exemplary-claim>
<us-field-of-classification-search>
<classification-national>
<country>US</country>
<main-classification>705  2</main-classification>
</classification-national>
</us-field-of-classification-search>
<figures>
<number-of-drawing-sheets>7</number-of-drawing-sheets>
<number-of-figures>7</number-of-figures>
</figures>
<us-related-documents>
<related-publication>
<document-id>
<country>US</country>
<doc-number>20090319311</doc-number>
<kind>A1</kind>
<date>20091224</date>
</document-id>
</related-publication>
</us-related-documents>
<us-parties>
<us-applicants>
<us-applicant sequence="001" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Mi</last-name>
<first-name>Zhe Cheng</first-name>
<address>
<city>Lawrenceville</city>
<state>GA</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
<us-applicant sequence="002" app-type="applicant" designation="us-only">
<addressbook>
<last-name>Russell</last-name>
<first-name>Rita Sue</first-name>
<address>
<city>Atlanta</city>
<state>GA</state>
<country>US</country>
</address>
</addressbook>
<residence>
<country>US</country>
</residence>
</us-applicant>
</us-applicants>
<inventors>
<inventor sequence="001" designation="us-only">
<addressbook>
<last-name>Mi</last-name>
<first-name>Zhe Cheng</first-name>
<address>
<city>Lawrenceville</city>
<state>GA</state>
<country>US</country>
</address>
</addressbook>
</inventor>
<inventor sequence="002" designation="us-only">
<addressbook>
<last-name>Russell</last-name>
<first-name>Rita Sue</first-name>
<address>
<city>Atlanta</city>
<state>GA</state>
<country>US</country>
</address>
</addressbook>
</inventor>
</inventors>
<agents>
<agent sequence="01" rep-type="attorney">
<addressbook>
<orgname>Sutherland Asbill &#x26; Brennan LLP</orgname>
<address>
<country>unknown</country>
</address>
</addressbook>
</agent>
</agents>
</us-parties>
<assignees>
<assignee>
<addressbook>
<orgname>McKesson Financial Holdings</orgname>
<role>03</role>
<address>
<city>Hamilton</city>
<country>BM</country>
</address>
</addressbook>
</assignee>
</assignees>
<examiners>
<primary-examiner>
<last-name>Nguyen</last-name>
<first-name>Hiep V</first-name>
<department>3686</department>
</primary-examiner>
</examiners>
</us-bibliographic-data-grant>
<abstract id="abstract">
<p id="p-0001" num="0000">Embodiments of the invention can provide systems and methods for real-time monitoring and analysis of prescription claim rejections. In one embodiment, a transaction performance monitoring system for facilitating real-time monitoring of the rejection of claims can be provided. The transaction performance monitoring system can include a transaction performance monitoring application operable to receive a plurality of claims associated with at least one dispenser, wherein each of the claims relates to at least one prescription and at least one payor. In addition, a transaction performance monitoring application operable to, in real-time, identify rejected claims and associated causes of the rejected claims. Furthermore, a transaction performance monitoring system can include a network operable to communicate the plurality of claims between the at least one dispenser and the at least one payor.</p>
</abstract>
<drawings id="DRAWINGS">
<figure id="Fig-EMI-D00000" num="00000">
<img id="EMI-D00000" he="206.84mm" wi="174.58mm" file="US08626525-20140107-D00000.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00001" num="00001">
<img id="EMI-D00001" he="220.98mm" wi="173.48mm" file="US08626525-20140107-D00001.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00002" num="00002">
<img id="EMI-D00002" he="125.90mm" wi="125.98mm" file="US08626525-20140107-D00002.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00003" num="00003">
<img id="EMI-D00003" he="237.15mm" wi="173.74mm" orientation="landscape" file="US08626525-20140107-D00003.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00004" num="00004">
<img id="EMI-D00004" he="229.28mm" wi="176.70mm" orientation="landscape" file="US08626525-20140107-D00004.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00005" num="00005">
<img id="EMI-D00005" he="232.24mm" wi="176.78mm" orientation="landscape" file="US08626525-20140107-D00005.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00006" num="00006">
<img id="EMI-D00006" he="237.49mm" wi="177.12mm" orientation="landscape" file="US08626525-20140107-D00006.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00007" num="00007">
<img id="EMI-D00007" he="234.95mm" wi="174.16mm" orientation="landscape" file="US08626525-20140107-D00007.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
</drawings>
<description id="description">
<?BRFSUM description="Brief Summary" end="lead"?>
<heading id="h-0001" level="1">FIELD OF THE INVENTION</heading>
<p id="p-0002" num="0001">The invention generally relates to prescriptions, and more particularly, to systems and methods for real-time monitoring and analysis of prescription claim rejections.</p>
<heading id="h-0002" level="1">BACKGROUND OF THE INVENTION</heading>
<p id="p-0003" num="0002">In a conventional prescription claim billing process, a payor/processor may return a particular claim to a pharmacy as a reject. Rejects may be anomalies or there may be a global issue that causes an abnormally high occurrence of rejects. The global issue may be with the payor/processor or with the pharmacy. These types of issues typically require manual intervention for resolution, which can be time consuming and expensive. For instance, if conventional processes are followed, it may take an inordinate amount of time and a relatively high number of similar rejects to notify each relevant party of the associated issue or reason for the reject. In some instances, identification of an issue or reason for the reject may be based on anecdotal evidence which may not be timely or an accurate indicator of the issue or reason for the reject. This may result in the reject of many other or subsequent prescriptions claims and customers may not be accommodated in a timely manner.</p>
<p id="p-0004" num="0003">Therefore, a need exists for systems and methods for real-time monitoring and analysis of prescription claim rejections.</p>
<p id="p-0005" num="0004">In addition, a need exists for systems and methods for a transaction performance monitoring system for facilitating the real-time monitoring of the rejection of prescription claims.</p>
<p id="p-0006" num="0005">Therefore, a need exists for systems and methods for a transaction performance monitoring application for facilitating real-time monitoring and analysis of rejections of prescription claims communicated between at least one dispenser and at least one payor.</p>
<heading id="h-0003" level="1">SUMMARY OF THE INVENTION</heading>
<p id="p-0007" num="0006">Embodiments of the invention can provide some or all of the above needs. Embodiments of the invention can provide systems and methods for real-time monitoring and analysis of prescription claim rejections. Moreover, embodiments of the invention can provide systems and methods for a transaction performance monitoring system for facilitating real-time monitoring of the rejection of prescription claims. In addition, embodiments of the invention can provide systems and methods for a transaction performance monitoring application for facilitating real-time monitoring and analysis of the rejections of prescription claims communicated between at least one dispenser and at least one payor.</p>
<p id="p-0008" num="0007">In one embodiment, a transaction performance monitoring system for facilitating real-time monitoring of the rejection of prescription claims can be provided. The transaction performance monitoring system can include a transaction performance monitoring application operable to receive a plurality of claims associated with at least one dispenser, wherein each of the claims relates to at least one prescription and at least one payor. In addition, a transaction performance monitoring application operable to, in real-time, identify rejected claims and associated causes of the rejected claims. Furthermore, a transaction performance monitoring system can include a network operable to communicate the plurality of claims between the at least one dispenser and the at least one payor.</p>
<p id="p-0009" num="0008">In accordance with another embodiment of the invention, a method for facilitating real-time monitoring of the rejection of prescription claims communicated between at least one dispenser and at least one payor can be implemented. The method can include receiving a plurality of claims associated with at least one dispenser, wherein each of the claims relates to at least one prescription and at least one payor. In addition, the method can include identifying, in real-time, rejected claims and associated causes of the rejected claims. Furthermore, the method can include outputting a real-time display of aggregated rejected claims and associated causes of the rejected claims.</p>
<p id="p-0010" num="0009">In another embodiment, a transaction performance monitoring application for facilitating the real-time monitoring of the rejection of prescription claims communicated between at least one dispenser and at least one payor via a network can be implemented. The transaction performance monitoring application can include computer-readable instructions operable to receive a plurality of claims associated with at least one dispenser, wherein each of the plurality of claims relates to at least one prescription and at least one payor. In addition, the computer-readable instructions can be operable to, in real-time, identify rejected claims and associated causes of the rejected claims. Further, the computer-readable instructions can be operable to determining at least one NCPDP (National Council for Prescription Drug Programs) reject code associated with each rejected claim. Furthermore, the computer-readable instructions can be operable to provide a user interface for monitoring, in real-time, rejected claims and the associated causes of the rejected claims. Moreover, the computer-readable instructions can be operable to communicate at least a portion of the plurality of claims between the at least one dispenser and the at least one payor.</p>
<p id="p-0011" num="0010">Other systems and processes according to various embodiments of the invention will become apparent with respect to the remainder of this document.</p>
<?BRFSUM description="Brief Summary" end="tail"?>
<?brief-description-of-drawings description="Brief Description of Drawings" end="lead"?>
<description-of-drawings>
<heading id="h-0004" level="1">BRIEF DESCRIPTION OF THE DRAWINGS</heading>
<p id="p-0012" num="0011">Reference will now be made to the accompanying drawings, which are not necessarily drawn to scale, and wherein:</p>
<p id="p-0013" num="0012"><figref idref="DRAWINGS">FIG. 1</figref> illustrates an example system in accordance with an embodiment of the invention.</p>
<p id="p-0014" num="0013"><figref idref="DRAWINGS">FIG. 2</figref> illustrates an example method in accordance with an embodiment of the invention.</p>
<p id="p-0015" num="0014"><figref idref="DRAWINGS">FIGS. 3-7</figref> are example screenshots illustrating example systems and methods in accordance with embodiments of the invention.</p>
</description-of-drawings>
<?brief-description-of-drawings description="Brief Description of Drawings" end="tail"?>
<?DETDESC description="Detailed Description" end="lead"?>
<heading id="h-0005" level="1">DETAILED DESCRIPTION OF EMBODIMENTS OF THE INVENTION</heading>
<p id="p-0016" num="0015">The invention now will be described more fully hereinafter with reference to the accompanying drawings, in which embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will convey the scope of the invention. Like numbers refer to like elements throughout.</p>
<p id="p-0017" num="0016">As used herein, the terms &#x201c;dispenser&#x201d;, &#x201c;provider&#x201d;, &#x201c;pharmacy&#x201d;, &#x201c;subscriber&#x201d;, and their respective pluralized forms are used interchangeably throughout the description, and should be construed to cover any dispenser or provider of a prescription drug or substance.</p>
<p id="p-0018" num="0017">The terms &#x201c;transaction&#x201d;, &#x201c;claims transaction&#x201d;, &#x201c;claim transaction&#x201d;, &#x201c;claim&#x201d;, &#x201c;prescription claim&#x201d;, &#x201c;drug claim&#x201d;, and their respective pluralized forms are used interchangeably throughout the description, and should be construed to cover any form of data associated with a drug purchase on behalf of a customer or patient.</p>
<p id="p-0019" num="0018">The term &#x201c;payor&#x201d;, &#x201c;claim processor&#x201d;, &#x201c;payor/processor&#x201d;, &#x201c;insurance company&#x201d;, and their respective pluralized forms are interchangeably used throughout the description, and should be construed to cover any entity that reimburses any portion of a cost to a customer, patient, dispenser, provider, or other entity submitting a claim for reimbursement.</p>
<p id="p-0020" num="0019">The terms &#x201c;real-time&#x201d; and &#x201c;near real-time&#x201d; are interchangeably used throughout the description, and should be construed to mean processing, updating, or reacting to data at the same or approximately the same rate as data is received.</p>
<p id="p-0021" num="0020">The term &#x201c;computer-readable medium&#x201d; describes any form of memory or a propagated signal transmission medium. Propagated signals representing data and computer-executable instructions can be transferred between network devices and systems.</p>
<p id="p-0022" num="0021">The term &#x201c;interface&#x201d; should be construed to mean a communication link between a claims switch and another system, for instance, a client system or a payor/processor system.</p>
<p id="p-0023" num="0022"><figref idref="DRAWINGS">FIG. 1</figref> illustrates an example system in accordance with an embodiment of the invention. In this example, a transaction performance monitoring system <b>100</b> can include a claims switch <b>102</b> in communication with one or more client systems <b>104</b>A-<b>104</b>N via at least one network <b>106</b>, or via one or more separate networks. Client systems <b>104</b>A-N are typically associated with at least one dispenser or provider, for example, a pharmacy. In addition, the transaction performance monitoring system <b>100</b> can also be in communication with at least one payor/processor system <b>108</b>A-N via the at least one network <b>106</b>, or via one or more separate networks. Payor/processor systems are typically associated with at least one payor or processor, for example, an insurance company. In the example shown in <figref idref="DRAWINGS">FIG. 1</figref>, the transaction performance monitoring system <b>100</b> can monitor, analyze, and process one or more transactions, such as prescription claim transactions, via a real-time claims network. The transaction performance monitoring system <b>100</b> and associated components are shown by way of example, and in other embodiments, similar or different components, data inputs, and data outputs may exist.</p>
<p id="p-0024" num="0023">The claims switch <b>102</b> can be a switch operable to handle and process one or more claim transactions, such as prescription claims and drug claims. In one embodiment, a claims switch <b>102</b> can be a server, multiple servers, or any number of processor-based devices. The claims switch <b>102</b> is further operable to receive one or more claims transactions from any number of client systems <b>104</b>A-<b>104</b>N. Transactions received by the claims switch <b>102</b> can also include claims submitted by one or more client systems, such as <b>104</b>A-<b>104</b>N. As shown in <figref idref="DRAWINGS">FIG. 1</figref>, a claims switch <b>102</b> can include a processor <b>110</b>, a memory <b>112</b> with a transaction performance monitoring application <b>114</b>, a browser application program <b>115</b>, and a communication interface <b>116</b>. The processor <b>110</b> can be operable to execute the transaction performance monitoring application <b>114</b>, a browser application program <b>115</b> and/or other sets of computer-executable instructions stored in the memory <b>112</b>. In other embodiments, the processor <b>110</b> can be operable to access and read various associated computer-readable media having stored thereon data and/or computer-executable instructions for implementing certain methods according to embodiments of the invention. The communication interface <b>116</b> can be operable to receive input from a user, generate an output for the user, and communicate with one or more client systems <b>104</b>A-<b>104</b>N and one or more payor/processor systems <b>108</b>A-N. In some embodiments, a claims switch <b>102</b> can include various input/output (I/O) devices, such as a keyboard, mouse, printer, microphone, speaker, monitor, bar code readers/scanners, RFID readers, and the like. Furthermore, in some embodiments, a communication interface <b>116</b> may take any number of forms, such as a network interface card, a modem, a wireless network card, and the like.</p>
<p id="p-0025" num="0024">A transaction performance monitoring application <b>114</b> can implement or otherwise utilize any number of processes, tables, filters, lists, screens, devices or other routines to identify or otherwise select in real-time a portion of the received claims transactions as rejected claims. Examples of processes, tables, filters, lists, screens, devices or other routines can include, but are not limited to, a reject code table such as <b>117</b>, which may be stored in memory <b>112</b> or other associated data storage devices.</p>
<p id="p-0026" num="0025">In one embodiment, when prescription claims or transactions are transmitted from one or more payor/processor systems <b>108</b>A-<b>108</b>N, the claim switch <b>102</b> can receive the prescription claims or transactions via the network <b>106</b>. The transaction performance monitoring application <b>114</b> can compare or otherwise identify certain data in some or all of the prescription claims or transactions to, for example, a reject code table <b>117</b>, by which the transaction performance monitoring application <b>114</b> can identify which of the received prescription claims or transactions are rejected claims. The transaction performance monitoring application <b>114</b> could either identify certain prescription claims or transactions as rejected claims by determining that certain data, for example, a rejection code exists in a prescription claim or transaction. In another instance, the transaction performance monitoring application <b>114</b> could either identify certain prescription claims or transactions as rejected claims by comparing whether certain data in a prescription claim or transaction matches a rejection code in the reject code table <b>117</b>. In either instance, the transaction performance monitoring application <b>114</b> can process prescription claims or transactions in real-time or near real-time to identify certain prescription claims or transactions as rejected claims.</p>
<p id="p-0027" num="0026">In one embodiment, a reject code table <b>117</b> can include a predefined list of one or more NCPDP (National Council for Prescription Drug Programs) reject codes, and a corresponding list of associated reject causes. For example, a reject code table can include a list of NCPDP reject codes in one column, and a list of corresponding reject causes corresponding to each of the NCPDP reject codes can be in a second column. In other embodiments, a reject code can be numeric, text, alphanumeric, or any combination of symbols used to indicate a rejected prescription claim or transaction. A corresponding reject cause can be an explanation used to indicate a cause or reason for why a particular prescription claim or transaction has been rejected. Example reject codes can include, but are not limited to, 01, 1C, 28, *95, AA, and 1001. Example corresponding reject causes can include, but are not limited to, missing/invalid BIN number, missing/invalid smoker/non-smoker code, missing/invalid date prescription written, time out, patient spenddown not met, and required segment missing. Other lists, data, or information in a reject code table can exist, and can be compared with reject codes associated with prescription claims or transactions by a transaction performance monitoring application <b>114</b>.</p>
<p id="p-0028" num="0027">In certain embodiments, the transaction performance monitoring application <b>114</b> may implement one or more different reject code tables for different dispensers or providers <b>104</b>A-N and/or different payor/processor systems, such as <b>108</b>A-N.</p>
<p id="p-0029" num="0028">In one embodiment, a transaction performance monitoring application, such as <b>114</b>, can be operable to receive a plurality of claims associated with at least one dispenser, wherein each of the claims relates to at least one prescription and at least one payor.</p>
<p id="p-0030" num="0029">In another embodiment, a transaction performance monitoring application, such as <b>114</b>, can be operable to receive, from a claims switch, a plurality of claims associated with at least one dispenser, wherein each of the claims relates to at least one prescription and at least one payor.</p>
<p id="p-0031" num="0030">In one embodiment, a transaction performance monitoring application, such as <b>114</b>, can provide a user interface that provides insight for a user into the performance of claim transactions traffic through a network, such as network <b>106</b>, or the RelayHealth Intelligent Network. In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can be a web-enabled application or service operable to provide a relatively efficient, secure means to monitor, view, and respond to claim transaction processing status from any number of browser application program-equipped client systems, payor/processors, clients, servers, hosts, systems, or corporate data centers.</p>
<p id="p-0032" num="0031">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate viewing claim transaction information in real-time or near real-time. For example, using a transaction performance monitoring application, such as <b>114</b>, a user can view real-time claim transaction performance data as well as sixty (60) days of historical information about the performance of claim transactions processed by a network, such as network <b>106</b> or the RelayHealth Intelligent Network.</p>
<p id="p-0033" num="0032">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate centralized or remote monitoring of claims processed through a network, such as network <b>106</b> or the RelayHealth Intelligent Network.</p>
<p id="p-0034" num="0033">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate real-time or near real-time monitoring of claim transactions processing, and can provide user notifications of predefined claim transaction response levels.</p>
<p id="p-0035" num="0034">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate recognition of claim transaction processing issues and problems, and can facilitate immediate addressing of such issues and problems.</p>
<p id="p-0036" num="0035">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can verify or otherwise validate inbound and outbound claim processing traffic between a plurality of dispensers or providers, a network such as network <b>106</b> or the RelayHealth Intelligent Network, and a plurality of payor/processors.</p>
<p id="p-0037" num="0036">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can provide real-time alerts regarding claim transaction rejects and/or system timeouts via a user interface such as display monitor operable to provide respective color changes for various alerts.</p>
<p id="p-0038" num="0037">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate viewing claim transaction reject level information at the interface or BIN level.</p>
<p id="p-0039" num="0038">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate user selectable alert thresholds at the interface, BIN or NCPDP reject code level.</p>
<p id="p-0040" num="0039">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate analysis of claim transaction performance traffic statistics and associated details at the interface or BIN level.</p>
<p id="p-0041" num="0040">In certain embodiments, a transaction performance monitoring application, such as <b>114</b>, can facilitate one or more user reports, for instance, user downloads of displayed claim transaction performance information via an output format such as a CSV-type (comma separated values) file.</p>
<p id="p-0042" num="0041">Although a single transaction performance monitoring application <b>114</b> is shown at the claims switch <b>102</b> in <figref idref="DRAWINGS">FIG. 1</figref>, other embodiments may have multiple instances of transaction performance monitoring applications similar to <b>114</b>. Such embodiments can include hosting other transaction performance monitoring applications similar to <b>114</b> in various system components including, but not limited to, one or more client systems <b>104</b>A-<b>104</b>N, components associated with the network <b>106</b>, or one or more payor/processor systems <b>108</b>A-N.</p>
<p id="p-0043" num="0042">A transaction performance monitoring application, such as <b>114</b>, may operate in conjunction with, may include additional instructions, or otherwise access other application program modules for performing other pre-processing or post-processing methods described herein. One may appreciate that the claims switch <b>102</b> may include alternate and/or additional components, hardware or software.</p>
<p id="p-0044" num="0043">In one embodiment, a transaction performance monitoring application, such as <b>114</b>, can include computer-readable instructions or computer code operable to receive a plurality of claims associated with at least one dispenser, wherein each of the plurality of claims relates to at least one prescription and at least one payor. In addition, such computer-readable instructions or computer code can be operable to, in real-time, identify rejected claims and associated causes of the rejected claims. Furthermore, such computer-readable instructions or computer code can be operable to determine at least one NCPDP (National Council for Prescription Drug Programs) reject code associated with each rejected claim. Further, such computer-readable instructions or computer code can be operable to provide a user interface for monitoring, in real-time, rejected claims and the associated causes of the rejected claims. Moreover, such computer-readable instructions or computer code can be operable to communicate at least a portion of the plurality of claims between the at least one dispenser and the at least one payor.</p>
<p id="p-0045" num="0044">In one embodiment, a transaction performance monitoring application can include computer-readable instructions or computer code operable to provide a real-time status of aggregated rejected claims and the associated causes of the rejected claims.</p>
<p id="p-0046" num="0045">In one embodiment, a transaction performance monitoring application can include computer-readable instructions or computer code operable to in-real-time, identify rejected claims and associated causes of the rejected claims based at least in part on determining at least one respective rejection code associated with each of the rejected claims.</p>
<p id="p-0047" num="0046">In one embodiment, a transaction performance monitoring application can include computer-readable instructions or computer code operable to provide a user interface for setting at least one alert triggered by a predefined percentage or number of rejected claims at a predefined level.</p>
<p id="p-0048" num="0047">In one embodiment, a predefined level comprises at least one of the following: interface level, BIN level, reject code level, reject code level within an interface, or reject code level within a BIN.</p>
<p id="p-0049" num="0048">In one embodiment, a transaction performance monitoring application can include computer-readable instructions or computer code operable to output at least one report comprising real-time data associated with rejected claims and associated causes of the rejected claims.</p>
<p id="p-0050" num="0049">The network <b>106</b> can be any telecommunication and/or data network, whether public, private, or a combination thereof, including a local area network, a wide area network, an intranet, an internet, the Internet, intermediate hand-held data transfer devices, and/or any combination thereof and may be wired and/or wireless. The network <b>106</b> may also allow for any combination of real-time, near real-time, off-line, and/or batch transactions to be transmitted between the claims switch <b>102</b>, client systems <b>104</b>A-<b>104</b>N, and payor/processor systems <b>108</b>A-N. Due to network connectivity, various methodologies as described herein may be practiced in the context of distributed computing environments. Although the client systems <b>104</b>A-<b>104</b>N and payor/processor systems <b>108</b>A-N are shown for simplicity as being in communication with the claims switch <b>102</b> via one intervening network <b>106</b>, it is to be understood that any other network configuration is possible. For example, intervening network <b>106</b> may include a plurality of networks, each with devices such as gateways and routers for providing connectivity between or among any number of networks. Instead of or in addition to a network <b>106</b> dedicated communication links may be used to connect the various components or devices of embodiments of the invention. In one example, a dedicated communication link can be used to facilitate relatively secure data transmission between any number of the client systems <b>104</b>A-N and the claims switch <b>102</b>, or alternatively, between the claims switch <b>102</b> and any number of the payor/processor systems <b>108</b>A-N.</p>
<p id="p-0051" num="0050">Each of the client systems, such as <b>104</b>A-<b>104</b>N, can be administered by a respective dispenser or provider, for example a pharmacy, as described above. In one embodiment, each of the client systems <b>104</b>A-<b>104</b>N can be any processor-driven device, such as a personal computer, laptop computer, handheld computer, or mainframe computer. As shown in <figref idref="DRAWINGS">FIG. 1</figref>, a client system, such as <b>104</b>A can include a processor <b>118</b>, a memory <b>120</b> with a browser application program <b>122</b>, and a communication interface <b>124</b>. The processor <b>118</b> can be operable to execute the browser application program <b>122</b> or other set of computer-executable instructions stored in the memory <b>120</b>. In other embodiments, the processor <b>118</b> can be operable to access and read various associated computer-readable media having stored thereon data and/or computer-executable instructions for implementing methods according to embodiments of the invention. The communication interface <b>124</b> can be operable to receive input from a user, generate an output for the user, and communicate with the claims switch <b>102</b> and one or more payor/processor systems <b>108</b>A-N as needed. For example, the browser application program <b>122</b> may include or otherwise facilitate access to the network <b>106</b> by way of other software, including a dedicated program, for interacting with the claims switch <b>102</b> and/or transaction performance monitoring application <b>114</b>. In one embodiment, a user, such as a pharmacist or other pharmacy employee, may utilize the browser application program <b>122</b> in preparing and providing a prescription drug request or order to the claims switch <b>102</b> for processing. The browser application program <b>122</b> can be utilized to retrieve or otherwise receive data from the claims switch <b>102</b>, including pricing and discount information for the prescription drug request or order. In some embodiments, client systems <b>104</b>A-<b>104</b>N can include various input/output (I/O) devices, such as a keyboard, mouse, printer, microphone, speaker, monitor, bar code readers/scanners, RFID readers, and the like. Furthermore, in some embodiments, a communication interface <b>124</b> may take any number of forms, such as a network interface card, a modem, a wireless network card, and the like. The client systems <b>104</b>A-<b>104</b>N may include additional instructions or access other program modules for performing other pre-processing or post-processing methods described herein. One may appreciate that the client systems <b>104</b>A-<b>104</b>N may include alternate and/or additional components, hardware or software.</p>
<p id="p-0052" num="0051">As described above, each of the payor/processor systems <b>108</b>A-<b>108</b>N can be administered by a respective payor, payor/processor, insurance company, or any entity that reimburses any portion of a cost to a customer, patient, dispenser, provider, or other entity submitting a claim for reimbursement. As shown in <figref idref="DRAWINGS">FIG. 1</figref>, each payor/processor system, such as <b>108</b>A, can include a processor <b>126</b>, a memory <b>128</b> with a browser application program <b>130</b>, and a communication interface <b>132</b>. The processor <b>126</b> can be operable to execute the browser application program <b>130</b> or other set of computer-executable instructions stored in the memory <b>128</b>. In the embodiment shown, the browser application program <b>130</b> can receive selected data from claims transactions from the claims switch <b>102</b>. In one embodiment, the browser application program <b>130</b> can perform some or all of the functionality described with respect to the browser application program <b>122</b> associated with the client systems <b>104</b>A-<b>104</b>N. In other embodiments, the processor <b>126</b> can be operable to access and read various associated computer-readable media having stored thereon data and/or computer-executable instructions for implementing methods according to embodiments of the invention. The communication interface <b>132</b> can be operable to receive input from a user, generate an output for the user, and communicate with the claims switch <b>102</b> and any number of the client systems <b>104</b>A-<b>104</b>N as needed. For example, the browser application program <b>130</b> may include or otherwise facilitate access to the network <b>106</b> by way of other software, including a dedicated program, for interacting with the claims switch <b>102</b> and/or transaction performance monitoring application <b>114</b>. In some embodiments, a payor/processor system, such as <b>108</b>A, can include various input/output (I/O) devices, such as a keyboard, mouse, printer, microphone, speaker, monitor, bar code readers/scanners, RFID readers, and the like. Furthermore, in some embodiments, a communication interface <b>132</b> may take any number of forms, such as a network interface card, a modem, a wireless network card, and the like. The payor/processor systems <b>108</b>A-<b>108</b>N may include additional instructions or access other program modules for performing other pre-processing or post-processing methods described herein. One may appreciate that the payor/processor systems <b>108</b>A-<b>108</b>N may include alternate and/or additional components, hardware or software.</p>
<p id="p-0053" num="0052">As illustrated in <figref idref="DRAWINGS">FIG. 1</figref>, the claims switch <b>102</b> may include or be in communication with at least one data storage device, such as database <b>134</b>. If the claims switch <b>102</b> includes a data storage device, then the data storage device could also be part of the memory <b>112</b>. The data storage device or database <b>134</b> and/or memory <b>112</b> may store, for example, previously received transactions and associated data, selected or rejected claim transactions and associated data, and any number of business rules, filters, or screens for processing transactions. Although a single data storage device or database <b>134</b> is referred to herein for simplicity, one will appreciate that multiple physical and/or logical data storage devices or databases may be used to store the above mentioned data. For security and performance purposes, the claims switch <b>102</b> may have a dedicated connection to the data storage device or database <b>134</b>, as shown. However, the claims switch <b>102</b> may also communicate with the data storage device or database <b>134</b> via a network <b>106</b>. In other embodiments of the invention, the claims switch <b>102</b> may include the data storage device or database <b>134</b> locally. The claims switch <b>102</b> may also otherwise be part of a distributed or redundant database management system (DBMS).</p>
<p id="p-0054" num="0053">Similar to the claims switch <b>102</b>, some or all of the payor/processor systems <b>108</b>A-<b>108</b>N may include or be in communication with at least one data storage device or database <b>136</b> with similar functionality to database <b>134</b>. In addition, some or all of the client systems <b>104</b>A-<b>104</b>N may include or be in communication with at least one data storage device or database <b>138</b> with similar functionality to database <b>134</b>.</p>
<p id="p-0055" num="0054">One will appreciate that components of the system <b>100</b> shown in and described with respect to <figref idref="DRAWINGS">FIG. 1</figref> are provided by way of example only. Numerous other operating environments, system architectures, and device configurations are possible. Accordingly, embodiments of the invention should not be construed as being limited to any particular operating environment, system architecture, or device configuration.</p>
<p id="p-0056" num="0055">Embodiments of a system, such as <b>100</b>, can facilitate real-time monitoring and analysis of prescription claim rejections. Furthermore, embodiments of a system, such as <b>100</b>, can facilitate real-time monitoring and analysis of the rejections of prescription claims communicated between at least one dispenser and at least one payor. In addition, embodiments of a system, such as <b>100</b>, can facilitate real-time monitoring and analysis of the rejections of prescription claims communicated between at least one dispenser and at least one payor via a network. Example operations of a system, such as <b>100</b> of <figref idref="DRAWINGS">FIG. 1</figref>, and its various components as well as associated methods and processes are described by reference to <figref idref="DRAWINGS">FIG. 2</figref>.</p>
<p id="p-0057" num="0056"><figref idref="DRAWINGS">FIG. 2</figref> is a process flowchart illustrating an example method in accordance with embodiments of the invention. The example method <b>200</b> shown in <figref idref="DRAWINGS">FIG. 2</figref> provides a method for real-time monitoring and analysis of rejections of claims communicated between at least one dispenser and at least one payor. The method <b>200</b> can be implemented by a system, such as <b>100</b> of <figref idref="DRAWINGS">FIG. 1</figref>.</p>
<p id="p-0058" num="0057">The method <b>200</b> begins at block <b>202</b>. In block <b>202</b>, a plurality of claims associated with at least one dispenser is received, wherein each of the claims relates to at least one prescription and at least one payor. For example, as shown in <figref idref="DRAWINGS">FIG. 1</figref>, one or more prescription claims or transactions associated with at least one prescription and at least one payor and originating at a client system, such as <b>104</b>A, can be received by a claims switch <b>102</b> or transaction performance monitoring application <b>114</b>. In another example, one or more prescription claims or transactions associated with at least one prescription and at least one payor and returned by a payor/processor, such as <b>108</b>A, can be received by a claims switch <b>102</b> or transaction performance monitoring application <b>114</b>. In any instance, a transaction performance monitoring application <b>114</b> associated with the claims switch <b>102</b> can process some or all of the received prescription claims or transactions.</p>
<p id="p-0059" num="0058">Block <b>202</b> is followed by block <b>204</b>, in which rejected claims and associated causes of the rejected claims are identified in real-time. In one embodiment, a transaction performance monitoring application <b>114</b> can implement in real-time one or more processes, filters, screens, devices, or other routines to identify some or all rejected prescription claims or transactions at a claim switch <b>102</b>, and to further identify associated causes of the rejected claims. In this example, a reject code table <b>117</b> can be implemented by the transaction performance monitoring application <b>114</b> to identify or otherwise select rejected prescription drug claims or transactions in real-time. In any instance, the transaction performance monitoring application <b>114</b> can, in real-time, identify or otherwise select one or more rejected prescription claims or claim transactions and associated causes of the rejected claims.</p>
<p id="p-0060" num="0059">In one embodiment, identifying rejected claims and associated causes of the rejected claims includes determining at least one respective rejection code associated with each of the rejected claims.</p>
<p id="p-0061" num="0060">In one embodiment, identifying rejected claims and associated causes of the rejected claims comprises determining at least one NCPDP (National Council for Prescription Drug Programs) reject code associated with each rejected claim.</p>
<p id="p-0062" num="0061">In one embodiment, the method <b>200</b> further includes setting at least one alert triggered by a predefined percentage or number of rejected claims at a predefined level.</p>
<p id="p-0063" num="0062">In one embodiment, a predefined level includes at least one of the following: interface level, BIN level, reject code level, reject code level within an interface, or reject code level within a BIN.</p>
<p id="p-0064" num="0063">Block <b>204</b> is followed by block <b>206</b>, wherein a real-time display of aggregated rejected claims and associated causes of the rejected claims is output. In this embodiment, as shown in <figref idref="DRAWINGS">FIG. 1</figref>, the transaction performance monitoring application <b>114</b> can facilitate a real-time display or output of identified or otherwise selected rejected prescription claims or transactions. As discussed above, the transaction performance monitoring application <b>114</b> can, in real-time, identify or otherwise select rejected prescription claims or transactions and associated causes of the rejected claims. The transaction performance monitoring application <b>114</b> can aggregate some or all of the rejected claims and associated causes of the rejected claims in a data storage device or memory, such as <b>112</b>. The transaction performance monitoring application <b>114</b> can generate an output for display of some or all of the rejected claims and associated causes of the rejected claims for transmission via a communication interface, such as <b>116</b>. In one example, a transaction performance monitoring application <b>114</b> can format and display some or all of the rejected claims and associated causes of the rejected claims. In this example, the transaction performance monitoring application <b>114</b> can output any number of real-time displays via the communication interface <b>116</b>, such as an output to a display monitor. The example screenshots in <figref idref="DRAWINGS">FIGS. 3-7</figref> described below represent example outputs of real-time displays to a display monitor.</p>
<p id="p-0065" num="0064">In one embodiment, a display further includes at least one of the following: summary information associated with a specific interface, one or more user specified parameters, a rejected claim total for a defined time period, or a status history associated with aggregated rejected claims.</p>
<p id="p-0066" num="0065">Other example outputs of a real-time display can be printed on a medium such as electronic or regular paper, graphical or visual indications, audio indications, or any other output operable to convey data associated with some or all of the rejected claims and associated causes of the rejected claims to a system user. In one embodiment, an output can be CSV-type (comma separated value) file, which can be imported into a variety of application programs for further processing and analysis. Such a file can include, but is not limited to, date, time, transaction numbers, response times, numbers of timeouts, timeout percentages, reject counts, percentages of rejects, reversal counts, percentages of reversals, and other real-time claims or transactions data.</p>
<p id="p-0067" num="0066">The method <b>200</b> of <figref idref="DRAWINGS">FIG. 2</figref> ends after block <b>206</b>.</p>
<p id="p-0068" num="0067">The example elements of <figref idref="DRAWINGS">FIG. 2</figref> are shown by way of example, and other process embodiments can have fewer or greater numbers of elements, and such elements can be arranged in alternative configurations in accordance with other embodiments of the invention. It will be understood that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, respectively, can be implemented by computer program instructions. These computer program instructions may be loaded onto a general purpose computer, special purpose computer such as a switch, or other programmable data processing apparatus to produce a machine, such that the instructions which execute on the computer or other programmable data processing apparatus create means for implementing the functions specified in the flowchart block or blocks.</p>
<p id="p-0069" num="0068">These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means that implement the function specified in the flowchart block or blocks. The computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational elements or steps to be performed on the computer or other programmable apparatus to produce a computer implemented process such that the instructions that execute on the computer or other programmable apparatus provide elements for implementing the functions specified in the flowchart block or blocks.</p>
<p id="p-0070" num="0069">Accordingly, blocks of the block diagrams and flowchart illustrations support combinations of means for performing the specified functions, combinations of elements or steps for performing the specified functions and program instruction means for performing the specified functions. It will also be understood that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, can be implemented by special purpose hardware-based computer systems that perform the specified functions, elements, or combinations of special purpose hardware and computer instructions.</p>
<p id="p-0071" num="0070"><figref idref="DRAWINGS">FIGS. 3-7</figref> are example screenshots illustrating example systems and methods in accordance with embodiments of the invention. In <figref idref="DRAWINGS">FIG. 3</figref>, an example screenshot illustrates a user interface <b>300</b> or &#x201c;dashboard&#x201d; with a real-time display provided by or otherwise facilitated by a transaction performance monitor application, such as <b>114</b> in <figref idref="DRAWINGS">FIG. 1</figref>. In this example, the user interface <b>300</b> includes a display of real-time inbound and outbound prescription claims or transactions traffic <b>302</b>, <b>304</b> between one or more client systems, such as <b>104</b>A-<b>104</b>N in <figref idref="DRAWINGS">FIG. 1</figref>, associated with respective dispensers, providers, or pharmacies, a claims switch, such as <b>102</b> in <figref idref="DRAWINGS">FIG. 1</figref>, and one or more payor/processor systems, such as <b>108</b>A-<b>108</b>N in <figref idref="DRAWINGS">FIG. 1</figref>, associated with respective payor/processors. The display as shown in <figref idref="DRAWINGS">FIG. 3</figref> can be updated in real-time, or in near real-time, by the transaction performance monitor application <b>114</b> as needed to reflect new or more recent prescription claims or transactions traffic. A user viewing and implementing the user interface <b>300</b> can pinpoint transaction timeouts and unacceptable reject levels. In addition, a user can monitor and analyze traffic statistics at various levels such as the interface, BIN, or reject code level. Furthermore, reduced administrative costs can result since claims monitoring can be centralized for an entity, and a user can quickly recognize and address traffic problems and associated issues.</p>
<p id="p-0072" num="0071">Each respective indicator for inbound traffic <b>302</b>, such as INBD<b>1</b> <b>306</b>, illustrates a particular prescription claim or transaction between at least one client system, such as <b>104</b>A, and a claims switch, such as <b>102</b>. Likewise, each respective indicator for outbound traffic <b>304</b>, such as OUTBD<b>1</b> <b>308</b>, illustrates a particular prescription claim or transaction between a claims switch, such as <b>102</b>, and at least one payor/processor system, such as <b>108</b>A. As new or recent claims or transactions are transmitted via the system <b>100</b>, the transaction performance monitor application <b>114</b> can generate a respective indicator representative of the inbound or outbound status of the particular prescription claim or transaction.</p>
<p id="p-0073" num="0072">Various functionality can be provided by the user interface <b>300</b> shown in <figref idref="DRAWINGS">FIG. 3</figref> including, but not limited to, filtering status types, viewing distinct color-based status indicators for alerting a user to certain conditions, clickable interfaces to provide additional details, and searching by BIN.</p>
<p id="p-0074" num="0073">In the embodiment shown in <figref idref="DRAWINGS">FIG. 3</figref>, one or more status type filters <b>310</b> can be provided to permit a user to click on or select a particular status type to filter some or all of the prescription claims or transactions, and view only those prescription claims or transactions having a certain status. For example, if a user selected status type filter <b>312</b> corresponding to &#x201c;RejCrt&#x201d;, the transaction performance monitoring application <b>114</b> can filter the some or all of the received prescription claims or transactions, and update the user interface <b>300</b> to display only those prescription claims or transactions corresponding to the status type filter selected. Example status type filters and corresponding status descriptions and colors can include, but are not limited to, Down=all transactions failed because of a time-out (Red), Critical=50% to 99.99% of transactions failed because of a time-out (Orange), Urgent=5% to 49.99% of the transactions failed because of a time-out, Normal=less than 5% of the transactions failed (Green), RejCrt=above 95% transactions are rejected other than time-outs for more than five consecutive samples (Pink), and RejUrg=above 60% transactions are rejected, other than time-outs for more than five consecutive samples (Yellow). Other filters, colors, and status descriptions can exist in accordance with other embodiments of the invention. In the manner described, a user can, in real-time, view inbound and outbound traffic of prescription claims or transactions via a user interface, such as <b>300</b>, filter some or all of the traffic, and understand a range of operating efficiencies for the traffic.</p>
<p id="p-0075" num="0074">In one embodiment, a transaction performance monitoring application <b>114</b> can identify whether each received prescription claim or transaction includes a certain reject or response code as described above with respect to <figref idref="DRAWINGS">FIG. 1</figref>. As a percentage of prescription claims or transactions with a particular response code increases, the transaction performance monitor application <b>114</b> can generate a change in color of a status indicator, for example, from green to blue to orange to red. Each color may indicate an increase in the number of transactions that return a &#x201c;time out&#x201d; reject code. In this example, other types of rejected claims can be indicated separately by either a yellow or pink color status indicator. In this manner, certain outbound traffic indicators <b>304</b> can be shown in a certain color depending on the particular reject or response code.</p>
<p id="p-0076" num="0075">In the embodiment shown in <figref idref="DRAWINGS">FIG. 3</figref>, various transaction statistics for inbound traffic, outbound traffic, or both can be illustrated. For example, an average response time <b>314</b> or average transaction time across some or all interfaces can be determined and shown. In another example, an average reject rate <b>316</b> or average transaction reject rate across some or all interfaces can be determined and shown. In this manner, a user can, in real-time, view an overall indicator of transaction velocity and reject rate for some or all of the traffic of prescription claims or transactions via a user interface, such as <b>300</b>.</p>
<p id="p-0077" num="0076">In the embodiment shown in <figref idref="DRAWINGS">FIG. 3</figref>, clickable interfaces <b>302</b>, <b>304</b>, <b>318</b>, <b>320</b>, <b>322</b> can provide additional details regarding a transaction. For example, a user clicking on a configuration button, such as &#x201c;CONFIG&#x201d; <b>322</b>, can obtain an alert configuration webpage described in detail in <figref idref="DRAWINGS">FIG. 4</figref> below. In another example, a user clicking on inbound interface <b>302</b> or outbound interface <b>304</b> can obtain a transaction analyzer webpage described in detail in <figref idref="DRAWINGS">FIG. 5</figref> below. In another example, a user clicking on a reject code alert interface <b>318</b> can obtain an error code BIN cross analyzer webpage described in detail in <figref idref="DRAWINGS">FIG. 7</figref> below. In another example, a user clicking on a third party BIN alert interface <b>320</b> can obtain a transaction analyzer webpage described in detail in <figref idref="DRAWINGS">FIG. 5</figref> below.</p>
<p id="p-0078" num="0077">In <figref idref="DRAWINGS">FIG. 4</figref>, an example screenshot illustrates a user interface <b>400</b> with a real-time display provided by or otherwise facilitated by a transaction performance monitor application, such as <b>114</b> in <figref idref="DRAWINGS">FIG. 1</figref>. In this example, the user interface <b>400</b> includes a display of real-time alert configurations for some or all of the interfaces displayed by the user interface <b>300</b> of <figref idref="DRAWINGS">FIG. 3</figref>. By way of the add button <b>401</b>, edit <b>402</b> and delete <b>404</b> commands, a user can set-up different alerts at various levels including, but not limited to, interface, BIN, reject code, reject code within an interface, and reject code within a BIN. As shown by alert <b>406</b>, an alert type at a BIN level with a name 99992 for reject code 36 can be set with certain predefined percentages of rejected claims and/or a number of rejected claims at a predefined level. In this manner, a user interface can be provided for setting at least one alert triggered by a predefined percentage or number of rejected claims at a predefined level.</p>
<p id="p-0079" num="0078">In <figref idref="DRAWINGS">FIG. 5</figref>, an example screenshot illustrates a user interface <b>500</b> with a real-time display provided by or otherwise facilitated by a transaction performance monitor application, such as <b>114</b> in <figref idref="DRAWINGS">FIG. 1</figref>. In this example, the user interface <b>500</b> includes a display of real-time claim or transaction details for some or all of the interfaces displayed by the user interface <b>300</b> of <figref idref="DRAWINGS">FIG. 3</figref>. Either inbound or outbound traffic can be analyzed by selecting a respective command <b>502</b>, <b>504</b>, or from a list of available interfaces <b>506</b>. By way of the report type command <b>508</b>, a user can select different report types including, but not limited to, status history or daily total report types. As shown by field <b>510</b>, chronologically ordered claims or transactions data can be displayed. In this example, claims or transactions data displayed can include, but is not limited to, number of transactions, response time, number of timeouts, timeout percentage, number of rejects, reject percentage, number of reversals, reversal percentage, and various reject analysis commands, such as &#x201c;ANALYZE&#x201d; <b>512</b>, to provide additional details for particular reject codes. Using a reject analysis command <b>512</b>, a user can view and sort some or all of details for particular reject codes associated with claims or transactions. A user clicking on a reject analysis command <b>512</b> can obtain a reject code analyzer webpage described in detail in <figref idref="DRAWINGS">FIG. 6</figref> below. In this manner, a user interface can be provided for viewing and obtaining real-time status of aggregated rejected claims and the associated causes of the rejected claims.</p>
<p id="p-0080" num="0079">In <figref idref="DRAWINGS">FIG. 6</figref>, an example screenshot illustrates a user interface <b>600</b> with a real-time display provided by or otherwise facilitated by a transaction performance monitor application, such as <b>114</b> in <figref idref="DRAWINGS">FIG. 1</figref>. In this example, the user interface <b>600</b> includes a display of real-time claim or transaction details for some or all of the interfaces displayed by the user interface <b>300</b> of <figref idref="DRAWINGS">FIG. 3</figref>. Using a level dropdown command <b>602</b>, a BIN number selection command <b>604</b>, and/or a date and time range selection command <b>606</b>, a user can obtain, display, and sort specific rejected claims or transactions corresponding to the selected levels, BIN number and/or date and time ranges. As shown by field <b>608</b>, summary total transactions counts, summary total reject counts, summary total rejects percentages, alphanumerically ordered claim rejection codes, corresponding causes for rejection, rejection count numbers, percentages of total transactions, and percentages of total rejects can be displayed and sorted. Using a reject code analysis command, such as a particular reject code <b>610</b>, a user can view some or all of details for particular reject codes associated with claims or transactions. A user clicking on a reject code analysis command, such as a particular reject code <b>610</b>, can obtain an error code analyzer webpage with details related to the specific reject code selected. In this manner, a user interface can be provided for viewing and obtaining real-time status of aggregated rejected claims and the associated causes of the rejected claims.</p>
<p id="p-0081" num="0080">In <figref idref="DRAWINGS">FIG. 7</figref>, an example screenshot illustrates a user interface <b>700</b> with a real-time display provided by or otherwise facilitated by a transaction performance monitor application, such as <b>114</b> in <figref idref="DRAWINGS">FIG. 1</figref>. In this example, the user interface <b>700</b> includes a display of real-time claim or transaction details for some or all of the interfaces displayed by the user interface <b>300</b> of <figref idref="DRAWINGS">FIG. 3</figref>. Using an error code dropdown command <b>702</b>, and/or a date and time range selection command <b>704</b>, a user can obtain, display, and sort specific rejected claims or transactions by BIN number corresponding to the selected reject codes and/or date and time ranges. As shown by field <b>706</b>, BIN numbers, payor/processor names, reject counts, total transactions, percentages of total transactions, total reject numbers, and percentage of total rejects can be displayed and sorted. Using BIN selection command <b>708</b>, a user can view some or all of details for particular BIN numbers associated with rejected claims or transactions. A user clicking on a BIN selection command <b>708</b> can obtain the transaction analyzer webpage with details related to the BIN number selected. In this manner, a user interface can be provided for viewing and obtaining real-time status of aggregated rejected claims and the associated causes of the rejected claims.</p>
<p id="p-0082" num="0081">The screenshots <b>300</b>, <b>400</b>, <b>500</b>, <b>600</b>, and <b>700</b> described above and in <figref idref="DRAWINGS">FIGS. 3-7</figref> are shown by way of example, and other configurations and functionality associated with a user interface for viewing and obtaining real-time status of aggregated rejected claims and the associated causes of the rejected claims can be provided in accordance with other embodiments of the invention.</p>
<p id="p-0083" num="0082">Many modifications and other embodiments of the invention will come to mind to one skilled in the art to which this invention pertains having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the invention is not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.</p>
<?DETDESC description="Detailed Description" end="tail"?>
</description>
<us-claim-statement>The claimed invention is:</us-claim-statement>
<claims id="claims">
<claim id="CLM-00001" num="00001">
<claim-text>1. A transaction performance monitoring system for facilitating real-time monitoring of the rejection of claims, the transaction performance monitoring system comprising:
<claim-text>a transaction performance monitoring application operable to:
<claim-text>receive a plurality of claims associated with at least one dispenser, wherein each of the claims relates to at least one prescription and at least one payor;</claim-text>
<claim-text>in real-time, identify rejected claims and associated causes of the rejected claims, wherein the rejected claims and associated causes are aggregated to define a total number of rejected claims and a total number for each associated cause; and</claim-text>
<claim-text>provide a user interface for the at least one payor to monitor inbound and outbound claim traffic in real-time, and to view the total number of rejected claims and total number for each associated cause at an interface level, BIN level, reject code level, reject code level within an interface, or a reject code level within a BIN;</claim-text>
<claim-text>provide a user interface for setting at least one alert triggered by a predefined percentage of rejected claims or by a predefined number of rejected claims, wherein the rejected claims are at a predefined level comprising at least one of an interface level, BIN level, reject code level within an interface, or reject code within a BIN; and</claim-text>
</claim-text>
<claim-text>a network operable to:
<claim-text>communicate the plurality of claims between the at least one dispenser and the at least one payor.</claim-text>
</claim-text>
</claim-text>
</claim>
<claim id="CLM-00002" num="00002">
<claim-text>2. The system of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the performance monitoring application is further operable to:
<claim-text>provide a user interface for monitoring rejected claims and the associated causes of the rejected claims.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00003" num="00003">
<claim-text>3. The system of <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein the user interface is operable to provide at least one of the following: summary information associated with a specific interface, one or more user specified parameters, a rejected claim total for a defined time period, or a status history associated with aggregated rejected claims.</claim-text>
</claim>
<claim id="CLM-00004" num="00004">
<claim-text>4. The system of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the performance monitoring application is further operable to:
<claim-text>provide a real-time status of aggregated rejected claims and the associated causes of the rejected claims.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00005" num="00005">
<claim-text>5. The system of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the performance monitoring application is further operable to:
<claim-text>in real-time, identify rejected claims and associated causes of the rejected claims based at least in part on determining at least one respective rejection code associated with each of the rejected claims.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00006" num="00006">
<claim-text>6. The system of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the performance monitoring application is further operable to:
<claim-text>provide a user interface for setting at least one alert triggered by a predefined percentage or number of rejected claims at a predefined level.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00007" num="00007">
<claim-text>7. The system of <claim-ref idref="CLM-00006">claim 6</claim-ref>, wherein the predefined level comprises at least one of the following: interface level, BIN level, reject code level, reject code level within an interface, or reject code level within a BIN.</claim-text>
</claim>
<claim id="CLM-00008" num="00008">
<claim-text>8. The system of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the performance monitoring application is further operable to:
<claim-text>output at least one report comprising real-time data associated with rejected claims and associated causes of the rejected claims.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00009" num="00009">
<claim-text>9. A method for facilitating real-time monitoring of the rejection of claims communicated between at least one dispenser and at least one payor, the method comprising:
<claim-text>receiving, by at least one processor, a plurality of claims associated with at least one dispenser, wherein each of the claims relates to at least one prescription and at least one payor;</claim-text>
<claim-text>in real-time, identifying, by the at least one processor, rejected claims and associated causes of the rejected claims, wherein the rejected claims and associated causes are aggregated to define a total number of rejected claims and a total number for each associated cause;</claim-text>
<claim-text>setting at least one alert triggered by a predefined percentage of rejected claims or by a predefined number of rejected claims, wherein the rejected claims are at a predefined level comprising at least one of an interface level, BIN level, reject code level within an interface, or reject code within a BIN; and</claim-text>
<claim-text>outputting, by the at least one processor, a real-time display of aggregated rejected claims and associated causes of the rejected claims, wherein the at least one payor can monitor inbound and outbound claim traffic in real-time, and view the total number of rejected claims and total number for each associated cause at an interface level, BIN level, reject code level, reject code level within an interface, or a reject code level within a BIN.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00010" num="00010">
<claim-text>10. The method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein identifying rejected claims and associated causes of the rejected claims comprises determining at least one respective rejection code associated with each of the rejected claims.</claim-text>
</claim>
<claim id="CLM-00011" num="00011">
<claim-text>11. The method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein identifying rejected claims and associated causes of the rejected claims comprises determining at least one NCPDP (National Council for Prescription Drug Programs) reject code associated with each rejected claim.</claim-text>
</claim>
<claim id="CLM-00012" num="00012">
<claim-text>12. The method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, further comprising:
<claim-text>setting at least one alert triggered by a predefined percentage or number of rejected claims at a predefined level.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00013" num="00013">
<claim-text>13. The method of <claim-ref idref="CLM-00012">claim 12</claim-ref>, wherein the predefined level comprises at least one of the following: interface level, BIN level, reject code level, reject code level within an interface, or reject code level within a BIN.</claim-text>
</claim>
<claim id="CLM-00014" num="00014">
<claim-text>14. The method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein the display further comprises at least one of the following: summary information associated with a specific interface, one or more user specified parameters, a rejected claim total for a defined time period, or a status history associated with aggregated rejected claims.</claim-text>
</claim>
<claim id="CLM-00015" num="00015">
<claim-text>15. A transaction performance monitoring application for facilitating real-time monitoring of the rejections of claims communicated between at least one dispenser and at least one payor via a network, the transaction performance monitoring application comprising computer-readable instructions operable to:
<claim-text>receive a plurality of claims associated with at least one dispenser, wherein each of the plurality of claims relates to at least one prescription and at least one payor;</claim-text>
<claim-text>in real-time, identify rejected claims and associated causes of the rejected claims, wherein the rejected claims and associated causes are aggregated to define a total number of rejected claims and a total number for each associated cause;</claim-text>
<claim-text>determining at least one NCPDP (National Council for Prescription Drug Programs) reject code associated with each rejected claim;</claim-text>
<claim-text>provide a user interface for monitoring, in real-time, rejected claims and the associated causes of the rejected claims, wherein the at least one payor can monitor inbound and outbound claim traffic in real-time, and view the total number of rejected claims and total number for each associated cause at an interface level, BIN level, reject code level, reject code level within an interface, or a reject code level within a BIN;</claim-text>
<claim-text>provide a user interface for setting at least one alert triggered by a predefined percentage of rejected claims or by a predefined number of rejected claims, wherein the rejected claims are at a predefined level comprising at least one of an interface level, BIN level, reject code level within an interface, or reject code within a BIN; and</claim-text>
<claim-text>communicate at least a portion of the plurality of claims between the at least one dispenser and the at least one payor.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00016" num="00016">
<claim-text>16. The transaction performance monitoring application of <claim-ref idref="CLM-00015">claim 15</claim-ref>, wherein the computer-readable instructions are further operable to:
<claim-text>provide a real-time status of aggregated rejected claims and the associated causes of the rejected claims.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00017" num="00017">
<claim-text>17. The transaction performance monitoring application of <claim-ref idref="CLM-00015">claim 15</claim-ref>, wherein the computer-readable instructions are further operable to:
<claim-text>in-real-time, identify rejected claims and associated causes of the rejected claims based at least in part on determining at least one respective rejection code associated with each of the rejected claims.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00018" num="00018">
<claim-text>18. The transaction performance monitoring application of <claim-ref idref="CLM-00015">claim 15</claim-ref>, wherein the computer-readable instructions are further operable to:
<claim-text>provide a user interface for setting at least one alert triggered by a predefined percentage or number of rejected claims at a predefined level.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00019" num="00019">
<claim-text>19. The transaction performance monitoring application of <claim-ref idref="CLM-00018">claim 18</claim-ref>, wherein the predefined level comprises at least one of the following: interface level, BIN level, reject code level, reject code level within an interface, or reject code level within a BIN.</claim-text>
</claim>
<claim id="CLM-00020" num="00020">
<claim-text>20. The transaction performance monitoring application of <claim-ref idref="CLM-00015">claim 15</claim-ref>, wherein the computer-readable instructions are further operable to:
<claim-text>output at least one report comprising real-time data associated with rejected claims and associated causes of the rejected claims. </claim-text>
</claim-text>
</claim>
</claims>
</us-patent-grant>
